Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs) are enzymes implicated in tumor invasion and microenvironment modulation.
• Elevated MMP levels in bladder cancer patients often correlate with more advanced disease stages.
• Genetic variations within MMP genes may influence bladder cancer progression.

Purpose of the Study:

• To investigate whether polymorphisms in matrix metalloproteinase (MMP) genes modify the risk of bladder cancer invasiveness.
• To determine if smoke exposure interacts with MMP gene polymorphisms to alter bladder cancer invasiveness risk.

Main Methods:

• A case-only study design was employed.
• Eleven single-nucleotide polymorphisms and one microsatellite polymorphism in MMP1, MMP2, MMP3, MMP8, MMP9, and MMP12 genes were analyzed.
• The study included 243 Caucasian patients with muscle-invasive bladder cancer and 315 with superficial disease.

Main Results:

• The MMP9 microsatellite allele (>=24 CA repeat) and the MMP12 -82 G allele were associated with an increased risk of bladder cancer invasiveness.
• Smokers carrying the MMP9 >=24 CA repeat allele exhibited a 5.16-fold increased risk of invasiveness compared to non-smokers with wild-type alleles.
• Smokers with the MMP12 G allele also showed an elevated risk of invasive bladder cancer.

Conclusions:

• Genetic variations in MMP genes are associated with the development of invasive bladder cancer.
• Gene-environment interactions, particularly involving smoking, may play a significant role in bladder cancer invasiveness.